James O Armitage

Summary

Affiliation: University of Nebraska Medical Center
Country: USA

Publications

  1. ncbi request reprint How I treat patients with diffuse large B-cell lymphoma
    James O Armitage
    The Joe Shapiro Professor of Medicine, University of Nebraska Medical Center, Omaha 68198 7680, USA
    Blood 110:29-36. 2007
  2. ncbi request reprint Clinically important variants of diffuse large B-cell lymphoma
    James O Armitage
    University of Nebraska Medical Center, Omaha, NE 68198 USA
    Transfus Apher Sci 49:27-30. 2013
  3. ncbi request reprint Is there a role for autotransplants in patients with follicular lymphoma in the rituximab era?
    James O Armitage
    University of Nebraska Medical Center, Omaha, NE, United States
    Transfus Apher Sci 49:24-6. 2013
  4. doi request reprint The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management
    James O Armitage
    University of Nebraska Medical Center, Omaha, NE 68198, USA
    Am J Hematol 87:511-9. 2012
  5. pmc My treatment approach to patients with diffuse large B-cell lymphoma
    James O Armitage
    Division of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE 68198 7835, USA
    Mayo Clin Proc 87:161-71. 2012
  6. doi request reprint Improving therapy for patients with aggressive lymphoma
    James O Armitage
    University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Transfus Apher Sci 44:179-82. 2011
  7. doi request reprint The importance of testing PET-directed therapy in patients with Hodgkin lymphoma
    James O Armitage
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Curr Hematol Malig Rep 6:155-6. 2011
  8. ncbi request reprint Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients
    James O Armitage
    University of Nebraska College of Medicine, Omaha, NE 68198 3332, USA
    J Clin Oncol 21:897-906. 2003
  9. ncbi request reprint The evolving role of autologous hematopoietic stem cell transplantation for the treatment of patients with lymphoma
    James O Armitage
    College of Medicine, University of Nebraska Medical Center, 986545 Nebraska Medical Center, Omaha, NE 68198, USA
    Curr Hematol Rep 2:363-5. 2003
  10. ncbi request reprint Lymphoma 2006: classification and treatment
    James O Armitage
    Section of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198, USA
    Oncology (Williston Park) 20:231-9; discussion 242, 244, 249. 2006

Detail Information

Publications123 found, 100 shown here

  1. ncbi request reprint How I treat patients with diffuse large B-cell lymphoma
    James O Armitage
    The Joe Shapiro Professor of Medicine, University of Nebraska Medical Center, Omaha 68198 7680, USA
    Blood 110:29-36. 2007
  2. ncbi request reprint Clinically important variants of diffuse large B-cell lymphoma
    James O Armitage
    University of Nebraska Medical Center, Omaha, NE 68198 USA
    Transfus Apher Sci 49:27-30. 2013
    ..Recognition of these variants and utilization of the appropriate treatments will improve the outcome for the patients. ..
  3. ncbi request reprint Is there a role for autotransplants in patients with follicular lymphoma in the rituximab era?
    James O Armitage
    University of Nebraska Medical Center, Omaha, NE, United States
    Transfus Apher Sci 49:24-6. 2013
    ..either autologous or allogeneic) in the care of these patients. A similar overall survival and less treatment related toxicity make autologous transplantation the better choice for most patients transplanted at first treatment failure. ..
  4. doi request reprint The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management
    James O Armitage
    University of Nebraska Medical Center, Omaha, NE 68198, USA
    Am J Hematol 87:511-9. 2012
    ..T-cell lymphomas make up approximately 10-15% of lymphoid malignancies. The frequency of these lymphomas varies geographically, with the highest incidence in parts of Asia...
  5. pmc My treatment approach to patients with diffuse large B-cell lymphoma
    James O Armitage
    Division of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE 68198 7835, USA
    Mayo Clin Proc 87:161-71. 2012
    ..Recognition that diffuse large B-cell lymphoma is not one disease, but a variety of clinicopathologic syndromes provides the opportunity to further improve our ability to benefit patients...
  6. doi request reprint Improving therapy for patients with aggressive lymphoma
    James O Armitage
    University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Transfus Apher Sci 44:179-82. 2011
    ..These possibilities will be the focus of clinical investigation over the next decade...
  7. doi request reprint The importance of testing PET-directed therapy in patients with Hodgkin lymphoma
    James O Armitage
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Curr Hematol Malig Rep 6:155-6. 2011
    ..Ongoing studies addressing this possibility have the potential to answer this question and need to be supported...
  8. ncbi request reprint Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients
    James O Armitage
    University of Nebraska College of Medicine, Omaha, NE 68198 3332, USA
    J Clin Oncol 21:897-906. 2003
    ..However, there is considerable debate over the incidence or risk of tMDS/AML in NHL patients treated with any particular modality and the factors that contribute to malignant transformation...
  9. ncbi request reprint The evolving role of autologous hematopoietic stem cell transplantation for the treatment of patients with lymphoma
    James O Armitage
    College of Medicine, University of Nebraska Medical Center, 986545 Nebraska Medical Center, Omaha, NE 68198, USA
    Curr Hematol Rep 2:363-5. 2003
  10. ncbi request reprint Lymphoma 2006: classification and treatment
    James O Armitage
    Section of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198, USA
    Oncology (Williston Park) 20:231-9; discussion 242, 244, 249. 2006
    ....
  11. ncbi request reprint Overview of rational and individualized therapeutic strategies for non-Hodgkin's lymphomas
    James O Armitage
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198 3332, USA
    Clin Lymphoma 3:S5-11. 2002
    ....
  12. ncbi request reprint The treatment of patients with aggressive non-Hodgkin's lymphoma
    James O Armitage
    University of Nebraska Medical Center, Omaha, Nebraska 68198, USA
    Oncology (Williston Park) 19:3-6. 2005
  13. doi request reprint Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation
    Keni Gu
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Hematol Oncol 30:143-9. 2012
    ..However, no significant differences were found in the 5-year overall or event-free survivals using any of these approaches. In conclusion, cell of origin fails to predict survival of DLBCL patients treated with AHSCT...
  14. ncbi request reprint A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival
    Christine P Hans
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Blood 101:2363-7. 2003
    ..However, patients with FL3 having a diffuse component of more than 50% have an inferior survival that is similar to the survival of those with DLBCL...
  15. doi request reprint Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
    Kai Fu
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Clin Oncol 26:4587-94. 2008
    ..However, with the addition of rituximab to standard chemotherapy, the prognostic significance of this subclassification of DLBCL is unclear...
  16. doi request reprint Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma
    Julie M Vose
    Department of Internal Medicine, Division of Hematology Oncology, University of Nebraska Medical Center, Omaha, Nebraska 68198 7680, USA
    Biol Blood Marrow Transplant 19:123-8. 2013
    ..A follow-up phase III trial with 131-Iodine tositumomab/BEAM vs rituximab/BEAM was planned based on this information...
  17. doi request reprint Late relapse in patients with diffuse large B-cell lymphoma
    Julie M Vose
    Department of Internal Medicine, Section of Hematology Oncology, University of Nebraska Medical Center, Omaha, NE, USA
    Br J Haematol 151:354-8. 2010
    ..A small percentage of the late relapsing patients can have a prolonged second remission. However, the overall survival from the time of relapse was not different between early and late relapsing patients with most succumbing to lymphoma...
  18. ncbi request reprint CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience
    Julie M Vose
    Section of Hematology Oncology, University of Nebraska Medical Center, Nebraska Medical Center, Omaha 68198 7680, USA
    Leuk Lymphoma 43:799-804. 2002
    ..However, patients of all ages who failed CNOP and who were able to receive HDC and ASCT demonstrated long-term disease survival after the transplant...
  19. ncbi request reprint Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group
    James Z Huang
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Leuk Lymphoma 45:1551-7. 2004
    ..Our findings suggest that patients with DLBCL arising in NLPHL have a prognosis similar to those with de novo DLBCL and should be treated aggressively...
  20. ncbi request reprint Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphoma
    Julie M Vose
    Section of Hematology Oncology, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Clin Oncol 23:461-7. 2005
    ....
  21. ncbi request reprint Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group
    James Z Huang
    Department of Pathology, University of Nebraska Medical Center, Omaha, NE, USA
    Leuk Lymphoma 44:1903-10. 2003
    ..In conclusion, our findings suggest that patients with DLBCL arising in NLPHL have a prognosis similar to those with de novo DLBCL and should be treated aggressively...
  22. ncbi request reprint Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index
    Julie M Vose
    Department of Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198 7680, USA
    Biol Blood Marrow Transplant 14:36-42. 2008
    ..These data suggest that transplantation earlier in the course of the disease for patients with follicular lymphoma with use of a monoclonal antibody-based regimen may lead to improved outcomes...
  23. ncbi request reprint Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma
    Basem M William
    Department of Internal Medicine Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE, USA
    Clin Lymphoma Myeloma Leuk 13:417-23. 2013
    ..No prospective trials have compared the effect of different conditioning regimens on outcomes...
  24. ncbi request reprint BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma
    Javeed Iqbal
    Leukemia Lymphoma Molecular Profiling Project, Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    J Clin Oncol 24:961-8. 2006
    ..DLBCL is heterogeneous, and the expression of BCL2 is variable within the two major subgroups of DLBCL, germinal center B-cell-like (GCB) and activated B-cell-like (ABC) DLBCL, as well as primary mediastinal DLBCL...
  25. ncbi request reprint ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia
    Avadhut D Joshi
    Department of Genetics, Cell Biology, Center for Research in Leukemia and Lymphoma, University of Nebraska Medical Center, Omaha, Nebraska 68198 6395, USA
    Clin Cancer Res 13:5295-304. 2007
    ..However, the genes associated with CLL patient subgroups with high and low CD38 expression and their potential role in disease progression is not known...
  26. doi request reprint BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab
    Javeed Iqbal
    Departments of Pathology and Microbiology and Hematology Oncology and College of Public Health, Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Clin Cancer Res 17:7785-95. 2011
    ..However, after the inclusion of rituximab (R) in the CHOP regimen, several conflicting observations about the prognostic value of BCL2 expression have been reported...
  27. pmc Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP
    Xin Huang
    Xin Huang, Bin Meng, Wenfeng Cao, and Kai Fu, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin Chengfeng Bi, West China Hospital, West China School of Medicine of Sichuan University, Chengdu, China Xin Huang, Bin Meng, Javeed Iqbal, Anamarija M Perry, Wenfeng Cao, Lynette M Smith, Chengfeng Bi, Chunsun Jiang, Timothy C Greiner, Dennis D Weisenburger, James O Armitage, Julie M Vose, Timothy W McKeithan, Wing C Chan, and Kai Fu, University of Nebraska Medical Center, Omaha, NE B Belinda Ding and B Hilda Ye, Albert Einstein College of Medicine, Bronx, NY Lisa Rimsza, University of Arizona, Tucson, AZ Andreas Rosenwald, University of Wurzburg, Department of Physiology and Biophysics
    J Clin Oncol 31:4520-8. 2013
    ..In this study, we investigated whether STAT3 activation can risk stratify patients with DLBCL...
  28. pmc BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma
    Javeed Iqbal
    Department of Pathology and Microbiology, University of Nebraska Medical Center, 983135 Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Am J Pathol 165:159-66. 2004
    ..However, despite this higher proliferative activity, there was no significant difference in overall or failure-free survival between the t(14;18)-positive and -negative subsets within the GCB subgroup...
  29. ncbi request reprint Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation
    Steven Z Pavletic
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Am J Hematol 78:265-74. 2005
    ..More studies are needed to determine whether cGVHD prognostic systems should be used interchangeably in patient populations receiving different stem-cell products...
  30. doi request reprint The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component
    Jamil Y Abuzetun
    Creighton University Medical Center, Omaha, NE, USA
    Br J Haematol 144:531-7. 2009
    ..The Stanford V chemotherapy regimen has an excellent treatment outcome for good prognosis patients with Hodgkin lymphoma. The results are compromised when radiotherapy is not utilized...
  31. ncbi request reprint Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
    Nicholas A Barber
    Department of Internal Medicine, Division of Hematology Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Clin Lymphoma Myeloma Leuk 13:392-7. 2013
    ..Aggressive lymphomas are usually more PET avid than the indolent subtypes. Therefore, it is possible that PET/CT may help distinguish NLPHL from THR-LBCL...
  32. ncbi request reprint Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion
    Avadhut D Joshi
    Department of Genetics, Center for Research in Leukemia and Lymphoma, University of Nebraska Medical Center, Omaha, NE 68198 6395, USA
    Cancer Genet Cytogenet 172:120-6. 2007
    ..These results indicate an association between BLA and reduced expression of ATM, suggesting a role for ATM in disease progression in B-CLL...
  33. doi request reprint Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma
    Marilu Nelson
    Human Genetics Laboratories, Munroe Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, NE 68198 5440, USA
    Br J Haematol 141:461-9. 2008
    ..Although, genetic differences were noted in these subtypes, further studies are needed to determine the key pathogenetic events in PTCL...
  34. doi request reprint CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma
    Zdravko Mitrovic
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
    Br J Haematol 162:87-92. 2013
    ..The dismal outcome of CD43(+) cases in the non-GCB subgroup may be explained, at least in part, by a less favourable microenvironment...
  35. ncbi request reprint Follicular lymphoma: expanding therapeutic options
    Apar Kishor Ganti
    Department of Internal Medicine, University of Nebraska, Omaha, Nebraska, USA
    Oncology (Williston Park) 19:213-28; discussion 228, 233-6, 239. 2005
    ..Future directions in the treatment of follicular lymphoma include vaccines, antisense therapy, and proteasome inhibitors...
  36. ncbi request reprint Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease
    Julie M Vose
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 69198, USA
    J Clin Oncol 20:2344-52. 2002
    ....
  37. ncbi request reprint Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation
    Julie M Vose
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Leuk Lymphoma 48:683-90. 2007
    ..A dose of 0.2 mCi/kg ibritumomab tiuxetan is safe and effective for patients with progressive disease after high-dose chemotherapy and ASCT...
  38. doi request reprint B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases
    Anamarija M Perry
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Br J Haematol 162:40-9. 2013
    ..This B-cell lymphoma is a morphologically-recognizable entity with a spectrum of genetic abnormalities. New and better treatments are needed for this aggressive lymphoma...
  39. ncbi request reprint The role of mitoxantrone in non-Hodgkin's lymphoma
    James O Armitage
    College of Medicine, University of Nebraska Medical Center, Omaha 68198 6545, USA
    Oncology (Williston Park) 16:490-502, 507-8; discussion 511-2, 514. 2002
    ..Mitoxantrone is active in NHL, and combinations including mitoxantrone can be used effectively and may provide an advantage in the elderly...
  40. ncbi request reprint Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning
    Apar Kishor Ganti
    University of Nebraska Medical Center, Section of Oncology Hematology, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Clin Oncol 25:5643-8. 2007
    ..We conducted this analysis to determine if engagement in ACP among patients who undergo HSCT is associated with adverse outcomes...
  41. ncbi request reprint Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma
    Christine P Hans
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Mod Pathol 18:1377-84. 2005
    ..035). Cyclin D2 and PKC-beta expression will be useful in designing a 'biological prognostic index' for patients with DLBCL...
  42. pmc Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study
    Fausto R Loberiza
    Section of Oncology Hematology, Summer Undergraduate Research Program, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Clin Oncol 27:5376-82. 2009
    ....
  43. ncbi request reprint The aggressive peripheral T-cell lymphomas: 2013
    James O Armitage
    Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska
    Am J Hematol 88:910-8. 2013
    ..T-cell lymphomas make up approximately 10-15% of lymphoid malignancies. The frequency of these lymphomas varies geographically, with the highest incidence in parts of Asia...
  44. pmc Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma
    Timothy C Greiner
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Proc Natl Acad Sci U S A 103:2352-7. 2006
    ..This information on molecular phenotypes may provide new areas of investigation for ATM function or may be exploited by designing specific therapies for MCL cases with p53 aberrations...
  45. ncbi request reprint Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care
    Joslin M Bowen
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
    Br J Haematol 166:202-8. 2014
    ..Mandatory review of outside pathology material prior to treatment of patients for lymphoma will identify a significant number of misclassified cases with a major change in therapy. ..
  46. doi request reprint Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases
    Javier A Laurini
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
    Blood 120:4795-801. 2012
    ..0001). Our study provides new objective evidence that the distribution of NHL subtypes varies significantly by geographic region and should prompt epidemiologic studies to explain these differences...
  47. ncbi request reprint Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission
    Julie M Vose
    University of Nebraska Medical Center, Omaha 68198 7680, USA
    Biol Blood Marrow Transplant 10:116-27. 2004
    ..Exposure to myeloid growth factors to accelerate recovery for recipients of bone marrow grafts may increase the risk of disease progression or death...
  48. ncbi request reprint Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphoma
    Marin Nola
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Am J Hematol 77:31-5. 2004
    ..In multivariate analysis, the IPI score was the only significant predictor of OS. Anemia and B symptoms were additionally predictive of poor OS in patients with low IPI scores...
  49. ncbi request reprint Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study
    S S Joshi
    Department of Genetics, University of Nebraska Medical Center, Omaha, NE 986395, USA
    Cytotherapy 5:542-52. 2003
    ..This report describes the outcome and immune functions of a total of 50 HLA-matched related donor allogeneic blood stem-cell transplantation patients who received post-transplant G-CSF (10 microg/kg) or placebo...
  50. ncbi request reprint The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile
    James Z Huang
    Department of Pathology, The Munroe Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Blood 99:2285-90. 2002
    ..CD10 protein expression is useful in identifying cases of DLBCL with a germinal center B-cell gene expression profile and is often expressed in cases with the t(14;18)...
  51. ncbi request reprint Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen
    Colin D Weekes
    University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Clin Oncol 20:1087-93. 2002
    ..Because of an improved side-effect profile, the regimen of chlorambucil, vinblastine, procarbazine, and prednisone (ChlVPP) has been proposed for use in elderly patients...
  52. ncbi request reprint Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome
    Apar Kishor Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, Nebraska 68198 7680, USA
    Am J Hematol 79:206-10. 2005
    ..He is currently ambulatory and does not need wheelchair assistance. Hematopoietic stem-cell transplantation may be a treatment option for patients with multicentric Castleman disease and POEMS syndrome...
  53. doi request reprint Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
    Dennis D Weisenburger
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Blood 117:3402-8. 2011
    ..Thus, the IPI and a single pathologic feature could be used to stratify patients with PTCL-not otherwise specified for novel and risk-adapted therapies...
  54. ncbi request reprint Advances in follicular lymphoma
    Travis D Archuleta
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198 7860, USA
    Semin Oncol 31:66-71. 2004
    ..This article will review the available treatments for follicular lymphoma and discuss the studies supporting newer strategies of treatment...
  55. doi request reprint Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma
    Basem M William
    Division of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska Electronic address
    Biol Blood Marrow Transplant 20:536-42. 2014
    ..Determining relative efficacy of V-BEAM compared to BEAM would require a randomized trial...
  56. doi request reprint Association of number of follow-up providers with outcomes in survivors of hematologic malignancies
    Anthony J Cannon
    Section of Oncology Hematology, Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA
    Leuk Lymphoma 51:1862-9. 2010
    ..48, p = 0.44) after adjusting for patient factors. Our study showed that among survivors of hematologic malignancies, outcomes were not different for survivors who were seen by single or multiple follow-up providers...
  57. doi request reprint Salvage therapy for Hodgkin's lymphoma
    Fahd Quddus
    Section of Hematology and Oncology, UNMC Oncology Hematology Section, 987680 Nebraska Medical Center, University of Nebraska, Omaha, NE, USA
    Cancer J 15:161-3. 2009
    ..This article provides a review of the current literature regarding salvage therapy for HL...
  58. ncbi request reprint Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents
    K S Baker
    Department of Pediatrics, University of Nebraska Medical Center, Omaha, USA
    J Clin Oncol 17:825-31. 1999
    ....
  59. ncbi request reprint Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute myeloid leukemia
    Vijaya Raj Bhatt
    From the Department of Internal Medicine, Division of Hematology Oncology Human Genetics Laboratory, Munroe Meyer Institute for Genetics and Rehabilitation and Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska
    J Natl Compr Canc Netw 12:963-8. 2014
    ..This report shows that the use of allo-SCT with resultant graft-versus-leukemia effect and the addition of imatinib can result in long-term remission and possible cure in some patients with Ph(+)-AML. ..
  60. doi request reprint Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system
    Anamarija M Perry
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198 3135, USA
    Leuk Lymphoma 52:1681-8. 2011
    ..However, there is no significant difference in the frequency of the DLBCL subtypes compared to North America and Europe...
  61. pmc Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project
    Massimo Federico
    Universita di Modena e Reggio Emilia, Modena, Italy
    J Clin Oncol 31:240-6. 2013
    ..The International Peripheral T-Cell Lymphoma Project was undertaken to better understand the subtypes of T-cell and natural killer (NK) -cell lymphomas...
  62. pmc Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis
    Javeed Iqbal
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Blood 119:4939-48. 2012
    ..The other clusters showed enrichment of stroma-associated miRNAs, and also had higher expression of stroma-associated genes. Our clinical outcome analysis in the present study suggested that miRNAs can serve as prognosticators...
  63. ncbi request reprint Subcutaneous panniculitis-like T-cell lymphoma: presentation of 2 cases and observations
    Jason S Papenfuss
    Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, USA
    Clin Lymphoma 3:175-80. 2002
    ..In this report, we present 2 cases of subcutaneous panniculitis-like T-cell lymphoma with variable clinical courses. We also review the literature of this unusual lymphoma...
  64. ncbi request reprint Treatment of indolent non-Hodgkin's lymphoma with cladribine as single-agent therapy and in combination with mitoxantrone
    James O Armitage
    Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Int J Hematol 79:311-21. 2004
    ..Cladribine is highly effective as a single agent and in combination with mitoxantrone in the treatment of indolent NHL, and its availability broadens the range of therapeutic options for indolent NHL...
  65. ncbi request reprint The curability of follicular lymphoma
    Matthew Lunning
    University of Nebraska Medical Center, Omaha, NE 68583, USA
    Transfus Apher Sci 37:31-5. 2007
    ..Even in follicular lymphoma grade 1 and 2, some patients have durable responses to initial therapy, and a significant proportion of patients can have durable responses after hematopoietic stem cell transplantation...
  66. doi request reprint Acute coronary syndromes complicating the first infusion of rituximab
    Joel D Armitage
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Clin Lymphoma Myeloma 8:253-5. 2008
    ..Patients should be aware that this is a rare, albeit serious, complication of treatment with rituximab...
  67. ncbi request reprint Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group
    D D Weisenburger
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha 68198 3135, USA
    Am J Hematol 64:190-6. 2000
    ..We conclude that new therapeutic approaches, with the patients stratified by histologic type and clinical prognostic factors, are clearly needed for MCL...
  68. ncbi request reprint High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma
    P J Bierman
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198 3330, USA
    J Clin Oncol 15:445-50. 1997
    ..This study evaluated the results of high-dose therapy followed by autologous bone marrow or peripheral-blood stem-cell transplantation for patients with follicular low-grade non-Hodgkin's lymphoma...
  69. ncbi request reprint The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation
    P J Bierman
    Department of Internal Medicine, Section of Oncology Hematology, Omaha, NE 68198 3330, USA
    Ann Oncol 13:1370-7. 2002
    ..The purpose of this study was to determine whether this prognostic score would also be useful for Hodgkin's disease patients undergoing autologous hematopoietic stem cell transplantation...
  70. ncbi request reprint Hematopoietic cell transplantation: progress and obstacles
    M Devetten
    University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Ann Oncol 18:1450-6. 2007
    ..Long-term complications are starting to emerge, and will gain in importance in the near future...
  71. ncbi request reprint Hematopoietic stem cell transplantation in mantle cell lymphoma
    A K Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Ann Oncol 16:618-24. 2005
    ..The role of hematopoietic stem cell transplantation (HSCT) in MCL is unclear. Hence we decided to study the clinical course of patients who received autologous and allogeneic HSCT for MCL...
  72. ncbi request reprint Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor
    M R Bishop
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198 3330, USA
    J Clin Oncol 15:1601-7. 1997
    ....
  73. ncbi request reprint Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma
    J M Vose
    University of Nebraska Medical Center, Omaha 68198 7680, USA
    Biol Blood Marrow Transplant 7:680-7. 2001
    ....
  74. ncbi request reprint Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma
    J M Vose
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha 69198 3332, USA
    J Clin Oncol 16:844-9. 1998
    ....
  75. ncbi request reprint High-dose therapy in lymphomas: a review of the current status of allogeneic and autologous stem cell transplantation in Hodgkin's disease and non-Hodgkin's lymphoma
    S A Mink
    University of Nebraska Medical Center, Section of Oncology Hematology, Omaha, NE, USA
    Oncologist 6:247-56. 2001
    ..For follicular lymphomas, selected patients seem to benefit and studies are ongoing. Finally, the use of allogeneic stem cell transplantation can be useful in a select group of younger patients...
  76. ncbi request reprint Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project
    D D Weisenburger
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198 3135, USA
    Am J Hematol 67:172-8. 2001
    ..In contrast, patients with ALCL-B appear to be similar to those with other forms of DLBCL...
  77. ncbi request reprint High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma
    Z S Pavletic
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, USA
    Ann Oncol 9:1023-6. 1998
    ..However, the long-term utility of this therapy for B-CLL is unknown...
  78. ncbi request reprint Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry
    J M Vose
    Lymphoma Working Committee of the Autologous Blood and Marrow Transplant Registry, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI, USA
    J Clin Oncol 19:406-13. 2001
    ....
  79. ncbi request reprint Autologous hematopoietic stem cell transplantation for mantle cell lymphoma
    J M Vose
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198 7680, USA
    Biol Blood Marrow Transplant 6:640-5. 2000
    ..Whether this therapy will increase the overall survival or EFS in patients receiving transplants in first complete remission will need to be tested in prospective randomized clinical trials...
  80. ncbi request reprint Treatment of non-Hodgkin lymphoma
    R J Hauke
    Section of Hematology Oncology, University of Nebraska Medical Center, Omaha 68198 7680, USA
    Curr Opin Oncol 12:412-8. 2000
    ..Despite high treatment-related mortality rates, allogeneic transplantation in relapsed aggressive lymphoma warrants further investigation. Last, as patients are surviving longer, complications of therapy are having to be addressed...
  81. ncbi request reprint Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma
    J M Vose
    Department of Internal Medicine, Nebraska Medical Center, Omaha 68198 7680, USA
    Leuk Lymphoma 38:91-101. 2000
    ..Non-hematologic toxicities were mild and few in number. Further evaluation of this treatment is warranted and further dose escalation will be possible...
  82. ncbi request reprint Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma
    J M Vose
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198 3330, USA
    J Clin Oncol 14:2473-9. 1996
    ....
  83. doi request reprint The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project
    Zdravko Mitrovic
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, 68198 3135, USA
    Am J Hematol 87:790-4. 2012
    ..In this study, lymphopenia was identified as a new adverse prognostic factor in the lymphoma type of ATLL...
  84. ncbi request reprint Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
    Christine P Hans
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Blood 103:275-82. 2004
    ..0001). In summary, immunostains can be used to determine the GCB and non-GCB subtypes of DLBCL and predict survival similar to the cDNA microarray...
  85. ncbi request reprint Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation
    Steven Z Pavletic
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE, USA
    Transplantation 76:877-81. 2003
    ..5% donor CD3 lymphocytes. PT demonstrated lymphodepleting effects and promising safety, supporting alloNST as early as 7 days after initiation of PT...
  86. ncbi request reprint Genomic analysis of lymphoma: potential for clinical application
    Wing C Chan
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198 3135, USA
    J Natl Compr Canc Netw 8:353-60. 2010
    ..These techniques offer the promise of truly personalized medicine for patients with lymphoma...
  87. ncbi request reprint Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience
    A K Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, USA
    Ann Oncol 17:920-7. 2006
    ....
  88. ncbi request reprint Hematopoietic stem cell transplantation in hematologic malignancy
    T D Archuleta
    Section of Hematology Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA
    Panminerva Med 46:61-74. 2004
    ..Timing of transplantation and selection of patients are also discussed. New innovations in stem cell transplantation including umbilical cord blood and non-myeloablative transplantation are reviewed...
  89. ncbi request reprint Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantation
    M R Bishop
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
    J Clin Oncol 18:2269-72. 2000
    ..Filgrastim has also been observed to effectively treat leukemic relapse after alloSCT. A retrospective analysis was performed to determine the effectiveness of filgrastim in treating relapses after alloSCT...
  90. ncbi request reprint Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis
    Ted R Mikuls
    Department of Medicine, University of Nebraska Medical Center, Omaha, NE 68198 3025, USA
    J Clin Oncol 24:1597-602. 2006
    ..In this prospective study, we examined the association of RA with survival in patients with NHL...
  91. ncbi request reprint Is lymphoma occurring in the elderly the same disease?
    James O Armitage
    Department of Hematology, University of Nebraska Medical Center, Omaha, NE, USA
    Leuk Lymphoma 49:14-6. 2008
  92. ncbi request reprint Staging non-Hodgkin lymphoma
    James O Armitage
    Department of Internal Medicine, University of Nebraska Medicine Center, Omaha, NE, USA
    CA Cancer J Clin 55:368-76. 2005
    ..However, patients should also be classified using the International Prognostic Index. New insights into the biology of the lymphomas in the coming years might well improve our ability to evaluate patients and choose therapy...
  93. ncbi request reprint T-cell/NK-cell lymphomas: a review
    Amit W Panwalkar
    University of Nebraska Medical Center, Department of Oncology Hematology, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, United States
    Cancer Lett 253:1-13. 2007
    ..Novel therapeutic approaches continue to be explored, however will probably require larger clinical trials to establish their utility over the current standard...
  94. ncbi request reprint Clinical significance of hematologic parameters in non-Hodgkin's lymphoma at diagnosis
    M G Conlan
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha
    Cancer 67:1389-95. 1991
    ..These data suggest that hematologic evaluation at the time of diagnostic staging of NHL provides useful prognostic information that may have therapeutic implications...
  95. ncbi request reprint Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience
    H Tezcan
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68105, USA
    Leuk Lymphoma 34:273-85. 1999
    ..In conclusion, limited stage follicular lymphoma has an excellent initial response to radiation therapy or chemotherapy; however the recurrence rate is high and cure is limited...
  96. ncbi request reprint Clinical roundtable monograph. T-cell lymphoma: therapeutic overview and disease state awareness
    James O Armitage
    Internal Medicine Oncology Hematology Division University of Nebraska Medical Center Omaha, Nebraska, USA
    Clin Adv Hematol Oncol 8:1-15. 2010
    ..A number of these agents now show promise in the treatment of both frontline and relapsed/ refractory disease...
  97. ncbi request reprint Professionalism and cancer care
    James O Armitage
    University of Nebraska Medical Center Omaha, Nebraska, USA
    Oncology (Williston Park) 22:636-7. 2008
  98. ncbi request reprint Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization
    Bhavana J Dave
    Human Genetics Laboratories, Munroe Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, 985440 Nebraska Medical Center, Omaha, NE, USA
    Cancer Genet Cytogenet 132:125-32. 2002
    ..Overall, M-FISH has enhanced our ability to provide a comprehensive karyotypic analysis, and has helped in defining the importance of BCL3, BCL8, BCL9, and BCL10 carrying breakpoints in DLBCL...
  99. ncbi request reprint Advances in the management of patients with non-Hodgkin's lymphoma
    J M Lionberger
    University of Nebraska Medical Center, 986545 Nebraska Medical Center, Omaha, NE 68198-6545, USA
    Expert Rev Anticancer Ther 1:43-52. 2001
    ..This review describes therapeutic modalities that are currently being used or are in the process of being developed and which are based on concepts divergent from 'traditional' approaches to managing non-Hodgkin's lymphoma...
  100. ncbi request reprint Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: a review of 200 consecutive cases by a panel of five expert hematopathologists
    Kikkeri N Naresh
    Lymphoma Registry, Department of Pathology, Tata Memorial Hospital, Mumbai, India
    Leuk Lymphoma 45:1569-77. 2004
    ..This suggests that the distribution of the B-cell and T-cell lymphomas in the Indian population, except for lymphoblastic lymphoma, lies in between the Western world (mainly Caucasian) and the Orientals...
  101. ncbi request reprint Acute radiation injury: contingency planning for triage, supportive care, and transplantation
    Daniel Weisdorf
    Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, and Department of Medicine, Bridgeport Hospital, New Haven, CT, USA
    Biol Blood Marrow Transplant 12:672-82. 2006
    ..The hematology/oncology community is most suited to participate in such contingency planning, and the necessary elements for its success are reviewed...